Market_Media_Hub

  Market Research Future (MRFR) assessed the global mHealth applications market 2020 through the evaluation period 2018 to 2023. The mHealth applications market is expected to rise at 44.7% CAGR across the assessment period. By 2023, the mHealth applications market value can touch above USD 12.4 Bn. The growing demand for mHealth that aid smartphones track one’s wellbeing boosting convenience of patient and physicians can promote expansion of the market across the analysis period. Mobile applications are expected to offer better treatment outcomes and favorable lifestyle by curbing incidence of chronic disorders that can add momentum to the mHealth application market. Digital revolution and the introduction of disruptive smartphone solutions can further add to the impetus of the  mHealth Applications Market . The growing dependency on healthcare apps as they provide better patient experience and aids in accessing relevant health information can catalyse the mHealth market rise. The uni

  The global safety lancet market is predicted to touch USD 2,305.1 million at an 11.8% CAGR over the forecast period (2017-2023), as per the latest Market Research Future (MRFR) report. Safety lancets, simply put, are retractable needles which reduce risk of infection and prevent accidental pricks. It is receiving global acceptance and recognition owing to its various convenient characteristics that give it an edge over the traditional vein puncture methods. These features include safety while using, easy handling, and painless vein puncture. Safety lancets are single-use, sterile devices that are intended for capillary blood samplings. It has an extensive range of applications including coagulation tests, allergy tests, blood group test, HIV and HBO screening test, blood group test, cholesterol test, capillary blood micro sampling, and different other blood-based tests. No risk of sharp injuries, no risk of cross-infection, easy to use, pre-set, cost-effective, and no needle loading

  Market Research Future (MRFR) in their report on the global capnography market predicted a rise by 19.5% CAGR over the review period (2018-2027). The market is expected to record a substantial market valuation by the end of 2027. Capnography is the process to measure CO2 presence in the respiratory gases. It is mostly used during anesthesia in intensive care. The measurement is shown through a graph which is known as capnogram. The measurement of the CO2 in the arterial blood is essential in conditions such as congenital heart disease. It works by understanding the CO2 absorption through infrared radiation. Its analysis is fast, and accuracy is highly esteemed. Among other situations,  capnography market  works well with pulmonary perfusion, alveolar ventilation, respiratory patterns, and elimination of CO2 from breathing circuit and ventilator during anesthesia. MRFR in their report on the market makes an impactful analysis of the segments, along with their volume-wise and value-wis

  The global market report with details of the medical holography market has been analyzed by Market Research Future (MRFR) and as per the study, the market can settle for a remarkable CAGR of 33.7% during the forecast period of 2019 to 2025. Among the major traction providers for the market, its ability to allow viewers to see fully parallax and auto-stereoscopic 3D images are expected to set the market norms. This would also ensure a rise in the inclusion of minimally-invasive surgeries. The surging research funding to boost better technologies, development in infrastructure to boost the market intake and others are expected to trigger the market growth. There are numerous factors that is driving the growth of the  medical holography market . These factors according to MRFR (Market Research Future) report include increase in R&D activities being conducted by leading biotechnological and pharmaceutical companies, increasing clinical application in dentistry, surgical and radiologi

  The anticoagulation market is expected to register a CAGR of 7.80% during the forecast period 2020-2027, to reach USD 31,696.59 million by 2027. MRFR recognizes the following companies as the key players in the global anticoagulation market—Pfizer Inc (US), Sanofi (France), Novartis AG (Switzerland), GlaxoSmithKline plc (UK), Daiichi Sankyo Company, Limited, Inc. (Japan), Johnson & Johnson Services Inc (US), Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd (Switzerland), and Portola Pharmaceuticals, Inc(US).  Market Highlights The  global anticoagulation market  is expected to have a market value of USD 31,696.59million by 2027. Anticoagulants are medications that reduce blood clots and reduce the risk of serious health conditions such as heart attack, diabetes, and others. Blood clots formation occurs due to platelets sticking together and proteins in the blood combining to form a solid mass. In addition, some of the

  According to MRFR analysis, the global smart pulse oximeters market is expected to register a CAGR of ~7.8% from 2021 to 2027 and hold a value of ~USD 1,849.0 million by 2027. The booming geriatric population and rise in prevalence of cardiovascular and respiratory diseases drive the growth of the  smart pulse oximeters market . The growing awareness of chronic diseases and the rise in demand for smart medical devices for home care setting is further driving the market's growth. WHO estimated that the world population above 60 years would almost double from 12% to 22% by 2050. Moreover, cardiovascular diseases are the major cause of death globally, taking about 17.9 million lives each year. This increase in the geriatric population and cardiovascular diseases will ultimately drive the demand for smart oximeters. Many market players are dominating the global smart pulse oximeters market. The prominent players are involved in strategic agreements, product launches, and joint ventur

  According to MRFR analysis, the global point of care diagnostics/testing market is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027. The  global point of care diagnostics/testing market  is driven by several factors, such as increasing demand for remote diagnosis, rising demand for early-stage diagnosis products, and growing demand for minimally or non-invasive diagnostic products. Other factors such as the introduction of mobile healthcare technologies and wearable diagnostic devices, the emergence of new technologies for monitoring and imaging are creating opportunities for the market players.  The market players are involved in various strategic collaborations, mergers & acquisitions, product launches, cooperative development of the product, and investing in stock to expand their worldwide presence. For instance, in July 2020, Becton, Dickinson and Company (US) launched a rapid POC antigen test to diagnose SARS-CoV-2 in 15

  According to MRFR analysis, the global bionic ear market is expected to register a CAGR of~8.10% from 2021 to 2027 and hold a value of ~USD 26,980.20 million by 2027. The global bionic ear market is driven by the increasing prevalence of hearing disorders which are lifting the demand for the products. The increasing aging population is likely to create a larger patient pool of people with hearing loss. Many market players are dominating the  global bionic ear market . The kay market players are involved in strategic agreements, acquisitions & mergers, product launches, and joint ventures to sustain their market positions. These strategies would provide higher market shares for the players and strengthen their position in the market. Sonova and Advanced Bionics AG are some of the biggest global manufacturers and suppliers of bionic ears. For instance, in March 2019, Sivantos Inc. (US) and widex A/S (Denmark) merge to become WS Audiology. This move strengthens the company's pro